Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia
2020 · Science Translational Medicine · 200 citations
https://doi.org/10.1126/scitranslmed.aaz0463
H
Heidi Altmann
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
1.1K
Citations
15
h-index
20
i10-index
Heidi Altmann is an academic researcher from National Center for Tumor Diseases. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Immune Cell Function and Interaction & Myeloproliferative Neoplasms: Diagnosis and Treatment. The author has an h-index of 15, co-authored 57 publications.
ORCID: 0000-0003-1967-0330Papers by this author
worksBone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT
2019 · Nature Communications · 181 citations
https://doi.org/10.1038/s41467-019-08871-1
Multidrug-related protein 1 (MRP1) polymorphisms rs129081, rs212090, and rs212091 predict survival in normal karyotype acute myeloid leukemia
2020 · Annals of Hematology · 19 citations
https://doi.org/10.1007/s00277-020-04163-7
Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia
2020 · Biomarker Research · 12 citations
https://doi.org/10.1186/s40364-020-00200-9
Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON)
2024 · Infection · 12 citations
https://doi.org/10.1007/s15010-024-02226-9
Validating genetic variants in innate immunity linked to infectious events in acute myeloid leukemia post-induction chemotherapy
2024 · Genes and Immunity · 3 citations
https://doi.org/10.1038/s41435-024-00285-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat